Jason Beaubien

Jason Beaubien is NPR's Global Health and Development Correspondent on the Science Desk.

In this role, he reports on a range of health issues across the world. He's covered mass circumcision drives in Kenya, abortion in El Salvador, poisonous gold mines in Nigeria, drug-resistant malaria in Myanmar and tuberculosis in Tajikistan. He was part of a team of reporters at NPR that won a Peabody Award in 2015 for their extensive coverage of the West Africa Ebola outbreak. His current beat also examines development issues including why Niger has the highest birth rate in the world, can private schools serve some of the poorest kids on the planet and the links between obesity and economic growth.

Prior to becoming the Global Health and Development Correspondent in 2012, Beaubien spent four years based in Mexico City covering Mexico, Central America and the Caribbean. In that role, Beaubien filed stories on politics in Cuba, the 2010 Haitian earthquake, the FMLN victory in El Salvador, the world's richest man and Mexico's brutal drug war.

For his first multi-part series as the Mexico City correspondent, Beaubien drove the length of the U.S./Mexico border making a point to touch his toes in both oceans. The stories chronicled the economic, social and political changes along the violent frontier.

In 2002, Beaubien joined NPR after volunteering to cover a coup attempt in the Ivory Coast. Over the next four years, Beaubien worked as a foreign correspondent in sub-Saharan Africa, visiting 27 countries on the continent. His reporting ranged from poverty on the world's poorest continent, the HIV in the epicenter of the epidemic, and the all-night a cappella contests in South Africa, to Afro-pop stars in Nigeria and a trial of white mercenaries in Equatorial Guinea.

During this time, he covered the famines and wars of Africa, as well as the inspiring preachers and Nobel laureates. Beaubien was one of the first journalists to report on the huge exodus of people out of Sudan's Darfur region into Chad, as villagers fled some of the initial attacks by the Janjawid. He reported extensively on the steady deterioration of Zimbabwe and still has a collection of worthless Zimbabwean currency.

In 2006, Beaubien was awarded a Knight-Wallace fellowship at the University of Michigan to study the relationship between the developed and the developing world.

Beaubien grew up in Maine, started his radio career as an intern at NPR Member Station KQED in San Francisco and worked at WBUR in Boston before joining NPR.

The people on the front lines of tuberculosis control have their hands full, but their biggest challenge for the moment may be containing strains of the disease that are resistant to drugs.

Worldwide the number of TB cases is going down. The bad news is that the number of drug-resistant cases is going up. The World Health Organization estimates that the number of reported TB cases that were multi, extremely- or totally-drug resistant doubled between 2009 and 2011.

Haiti used to be a tourist hot spot in the Caribbean. Former U.S. President Bill Clinton regularly recounts how he and Hillary honeymooned in Haiti in 1975. There used to be a hopping Club Med just outside Port-au-Prince, but it closed in the '90s.

Now, the Haitian government is trying to revive some of its former allure, launching an aggressive campaign to market the poorest country in the hemisphere as a vacation hub.

President Michel Martelly says tourism could be a major driver of economic growth and could help lift Haitians out of poverty.

Saturday marks the third anniversary of the powerful earthquake that destroyed much of the Haitian capital, Port-au-Prince. The quake killed roughly 200,000 people and left 1.5 million Haitians homeless.

Despite billions of dollars in international aid and pledges to help Haiti rebuild from the disaster, very little new, permanent housing has been built. And about 350,000 Haitians are still living in squalid, makeshift camps — where they face an array of health challenges.

Most of us do everything possible to avoid mosquitoes. But one Italian researcher literally sacrifices her right arm to keep the lowly insects alive.

Chiara Adolina is studying a new malaria drug, and she needs the little suckers for her experiments. So she feeds them each day with her own blood.

She extends her arm into a mosquito cage to give the insects "breakfast." Several dozen mosquitoes spread across her forearm and jam their proboscises into her skin. "Can you see how fat they become?" she says. "Look at that tummy."

"Her business is robbery and coldblooded murder ... they call her Annie Awful ... She's a thief and a killer. She stops at nothing."

Counterfeit drugs are a growing scourge around the world. They're generating millions of dollars in revenue for organized crime and fueling the rise of drug-resistant parasites.

Anti-malarials are among the most popular drugs to fake. But these faux pharmaceuticals are particularly dangerous because malaria can kill a person in a matter of days.

Global efforts to combat malaria are under threat from new strains of drug-resistant malaria, which are cropping up in Southeast Asia.

Over the last decade, the number of malaria deaths around the world has dropped sharply, from just over 1 million in 2000 to roughly 600,000 last year.

Much of that progress is due to the widespread use of drugs containing artemisinin. The new malaria drugs quickly kill the parasite.

The Nigerian government has been slow to fulfill a promise it made last spring. And, its sluggishness is putting kids at risk for lead poisoning, the advocacy group Humans Rights Watch says.

Last May, the Nigerian government pledged roughly $5 million to clean up lead contamination around illegal gold mines in northwest Nigeria. But so far, that money hasn't been released.

Pakistan has made a lot of progress this year in wiping out polio. There are signs that one type of poliovirus is gone and transmission of other strains seems to be slowing.

But a recent outbreak of polio there has health officials concerned about the overall effectiveness of the effort to eliminate polio in that country.

Malaria remains a huge problem in much of the world, but over the past decade the number of people getting sick and dying from the disease has gone down dramatically.

Health workers attribute much of this progress to the widespread use of artemisinin-based drugs. The problem now is that resistance to these drugs is starting to develop in Southeast Asia.